Eulises Franco, MD
Eulises is a clinical research executive veteran, having served as Medical Director, Sanofi Genzyme, Central America and the Caribbean; Director Clinical Operations, ICON, LATAM; ICRO Manager, Novartis, LATAM; and founder of both Site Organizations and CROs. He is an epidemiological researcher and involved in the medical community in both Colombia and Mexico.
Mitchell Parrish, JD, RAC, CIP
Prior to H Clinical, Mitchell served as Managing Director, Everglade Rx, Executive VP & General Counsel, Advarra, and Associate Attorney, K&L Gates. Mitchell is on the Board of Directors for Life Science Washington, Faculty for RAPS, and a former Steering Committee Member for Harvard MRCT. He is a published author on FDA regulations and frequent public speaker on technology in clinical research.
Paloma de Almenara
Paloma has spent her career helping to bring promising products to market through traditional and decentralized models, having served as Regional Head for CROs, and as a CRA for companies such as Merck and Worldwide Clinical Trials. She is a leader in clinical research throughout all corners of Latin America but appreciates her home base remaining her native Peru.
Germán Maravilla, MD
Prior to H Clinical, Germán held several medical director positions in the decentralized trial field and was formerly associate physician at Centro de Psicología Integral de la Persona of the Universidad Finis Terrae. He remains active in the medical field in Argentina and is on the Board of Directors for the Institute of Medicine and Psychology.
Patricia Zurita, PharmB
Patricia is a clinical trial veteran having held roles throughout Latin America from CRA, to Compliance Manager, to Training Officer, to Clinical Trial Director, for Gilead, ICON, Novartis, and PRA. She is a Pharmacist by training and leverages her diverse background to maintain quality systems applicable throughout each of H Clinical’s business segments.
Prior to H Clinical, Gabriel served as an IT and Logistics Consultant and COO of medical facilities in South America. He is a leader in decentralized trials in Latin America and has supported the largest home trial operation ever performed in the region with visits performed in Argentina, Brazil, Chile, Colombia, Mexico, and Peru.
Arturo Garcia, PharmB, CCRP
Arturo has worked as a CRA and Project Manager throughout Latin America and in the U.S. having supported traditional and decentralized trials for Genzyme, PRA, and ICON. He is a former Pharmacist and operates with precision to ensure the success of each trial.
Alejandro Infante, MBA
Alejandro is an experienced pharmaceutical and research professional, having served in Latin America as the Finance and Accounting Manager for ICON and Chief of Accounting & Taxes, Pharma Sector, for Novartis. His understanding of clinical research extends beyond finance, having overseen customs and importation for large-scale clinical trials.
TAMPA - U.S./CORPORATE HEADQUATERS7901 4th St N, Suite 5706, St. Petersburg, FL 33702
MEXICO CITY – CENTRAL AMERICAN HEADQUARTERSAv. Insurgentes Sur No1605, Piso 15 Mod IV, Col. San Jose Insurgentes, Del. Benito Juarez, CP 03900, CDMX, Mexico
SAO PAULO – SOUTH AMERICAN HEADQUARTERSRua Salviano Jose Da Silva, No 225, Bairro El Dorado, Sao Jose Dos Campos, SP, Brazil